Jupiter Neurosciences reported a gross margin of 86.88% and a net margin of -11,645.68% for the quarter ended Jun 2026. These financial ratios cover 11 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||
| Gross Margin | 86.88% | ||||||||||
| EBT Margin | -11,645.68% | ||||||||||
| EBIT Margin | -11,313.45% | ||||||||||
| EBITDA Margin | -11,313.45% | ||||||||||
| Operating Margin | -11,313.45% | ||||||||||
| Net Margin | -11,645.68% | ||||||||||
| Efficiency | |||||||||||
| Inventory AverageInventory Avg. | 0.15M | ||||||||||
| Assets AverageAssets Avg. | 3.14M | 5.58M | 4.47M | 3.27M | 4.07M | 4.64M | |||||
| Invested CapitalInvested Cap. | -4.16M | -5.14M | 4.32M | 3.21M | 1.49M | 0.20M | 3.47M | 1.16M | |||
| Leverage & Solvency | |||||||||||
| Interest Coverage RatioInterest Cover | -17.89 | -9.17 | -8.68 | -9.90 | -4.60 | -47.74 | -0.00M | -0.00M | -0.00M | -44.97 | -30.27 |
| Debt Ratio | 11.03 | 7.09 | 0.02 | 0.03 | 0.04 | 0.06 | 0.95 | 0.41 | |||
| Times Interest Earned | -17.89 | -9.17 | -8.68 | -9.90 | -4.60 | -47.74 | -0.00M | -0.00M | -0.00M | -44.97 | -30.27 |
| Valuation | |||||||||||
| Price to EarningsP/E | -3.18 | -0.18 | -0.21 | -0.35 | -0.16 | -0.05 | |||||
| Price to SalesP/S | 5.76 | ||||||||||
| Price to BookP/B | 1.13 | 0.09 | 0.35 | 14.01 | -0.26 | -0.38 | |||||
| Enterprise Value | 0.95M | -2.44M | -1.40M | 0.08M | -3.32M | -1.38M | |||||
| EV to EBIT | -0.65 | 1.58 | 0.62 | -0.04 | 1.18 | 0.50 | |||||
| EV to EBITDA | -0.65 | 1.58 | 0.62 | -0.04 | 1.18 | 0.50 | |||||
| Market Capitalization | 4.72M | 0.27M | 0.47M | 0.80M | 0.47M | 0.14M | |||||
| Price to FCFP/FCF | -1.28 | -0.25 | -0.57 | -0.70 | -0.20 | ||||||
| EV to FCF | -0.26 | 2.29 | 1.70 | -0.07 | 1.40 | ||||||
| EV to CFO | -0.26 | 2.29 | 1.70 | -0.07 | 1.40 | ||||||
| Return Ratios | |||||||||||
| Return on Sales [ROS]ROS | -11,313.45% | ||||||||||
| Return on Capital Employed [ROCE]ROCE | -271.38% | -109.59% | -313.19% | -1,003.31% | 267.87% | -1,327.57% | |||||
| Return on Assets [ROA]ROA | -106.05% | -75.71% | -131.37% | -230.84% | -219.68% | -220.54% |